Stay updated on SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.

Latest updates to the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record is available again, with details on the SAGE-547 trial for super-refractory status epilepticus, including its design, eligibility criteria, locations, outcome measures, and results-related information.SummaryDifference77%

- Check19 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the inaccessible study record.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the usual study details and navigation. This reflects an access issue rather than a content update to the study record.SummaryDifference21%

Stay in the know with updates to SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.